Several case reports recorded excellent results when using octreotide for the treatment of advanced HCC [64, 128]; lanreotide was also found effective in metastatic HCC, and the positive response was correlated with SSTR2 expression [65]. This evidence concerns the gene SSTR2 and hepatocellular carcinoma.